Professional Services is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726
Sample Landing Page

Your services

Datamonitor Healthcare

Datamonitor Healthcare

Trailtrove

Trailtrove

Any other service

Any other service

New Strategy Reports & Analysis

 

From Datamonitor Healthcare

Biosimilars Portfolio and Pipeline Trends, 2016: Biosimilars are expected to drive significant cost savings for healthcare systems, yet there are many considerations that will affect the success of biosimilars, ranging from clinical development, regulatory approval, and ongoing legal disputes around patents. Find out more, click here

Data in Healthcare: Underpinning the Shift to Value: Data has always been at the heart of the research-based biopharmaceutical industry. Until recently, clinical trial data was the key determinant of a drug’s success or failure. Now, as the healthcare system shifts towards value-focused outcomes, that success depends on a far wider expanse of data, including outcomes and cost data, adherence rates and, increasingly, patient-reported data, behavioral and social media data. Find out more, click here

US Specialty Drug Market Access: High-touch specialty drugs for complex, chronic, high-cost, or rare diseases are an increasingly significant component of the US pharmaceutical market. A sharp growth in regulatory approvals accompanied by high prices has driven rapid increases in expenditure on specialty therapies by both public and private payers. Find out more, click here

 

From Scrip Intelligence

Pfizer Essential Health Is Staying Put And Has A Focused Strategy For Growth: With a new name and focused strategy, Pfizer’s Essential Health business has evolved since the acquisition of Hospira in 2015. Group President John Young outlined the company’s plans to transition a unit that was established to manage patent expirations to become a growth center.  Find out more, click here

Out-Going GSK CEO Andrew Witty Tells Pharma To Evolve Or Die: The veteran pharma executive Andrew Witty says time – if not already gone – is running out fast for those biopharma companies who have not yet begun their necessary structural transitions. Find out more, click here

Ask the analyst

Ask the analyst

Our experts will do the research and get back to you personally with the information you need. This helps you strengthen your knowledge and understanding of global pharmaceutical & biotech events and their implications.

Submit your questions
Scrip Intelligence

Scrip Intelligence

Pink Sheet

Pink Sheet

Ovum Forecaster

Ovum Forecaster

You can now get training that meets your needs

You can now get training that meets your needs

Highlights of our training sessions:

  • Online demo sessions available at times suitable to you
  • Show you how to set up alerts so it is never too late

Contact your account manager today to organize your training

Back to the top Back to the top